COM:UROGEN
UroGen Pharma
- Stock
Last Close
11.55
22/11 21:00
Market Cap
502.60M
Beta: -
Volume Today
390.58K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 52.50K - | 210.50K 300.95% | 158K 24.94% | 982K - | 3.40M 246.03% | 4.58M 34.74% | 5.00M 9.18% | |||
average payables | 1.80M - | 3.16M 75.03% | 6.49M 105.46% | 6.62M 2.00% | 3.98M 39.81% | 4.53M 13.71% | 5.66M 24.91% | 6.02M 6.44% | ||
average receivables | 41.50K - | 140.50K 238.55% | 99K 29.54% | 3.52M - | 9.38M 166.27% | 12.21M 30.15% | 14.07M 15.26% | |||
book value per share | 1.36 - | 1.36 0.16% | 7.05 417.70% | 5.72 18.90% | 8.78 53.58% | 4.42 49.63% | 0.38 91.49% | -3.89 1,133.56% | -2.26 41.88% | |
capex per share | -0.03 - | -0.06 130.90% | -0.03 51.96% | -0.04 27.45% | -0.02 55.46% | -0.06 252.36% | -0.03 39.68% | -0.01 66.90% | -0.01 39.59% | |
capex to depreciation | -2.66 - | -3.26 22.49% | -1.31 59.88% | -1.34 2.58% | -0.25 81.72% | -0.59 142.16% | -0.42 28.65% | -0.14 67.04% | -0.11 18.60% | |
capex to operating cash flow | 0.04 - | -0.17 495.48% | 0.03 117.07% | 0.01 47.02% | 0.00 69.49% | 0.01 150.74% | 0.01 22.80% | 0.00 67.25% | 0.00 12.44% | |
capex to revenue | -0.04 - | -0.03 16.21% | -0.50 1,394.49% | -18.06 3,536.90% | -0.10 99.43% | -0.02 84.80% | -0.00 74.79% | -0.00 40.57% | ||
cash per share | 1.50 - | 1.78 18.84% | 7.51 321.06% | 6.43 14.40% | 7.16 11.40% | 7.03 1.91% | 3.99 43.24% | 4.38 9.89% | 4.78 9.02% | |
days of inventory on hand | 1.37K - | 192.23 85.96% | 710.47 - | 342.00 51.86% | 206.25 39.69% | 221.20 7.25% | ||||
days payables outstanding | 24.51K - | 2.70K 88.99% | 1.73K 35.92% | 1.18K - | 409.52 65.39% | 263.57 35.64% | 253.99 3.63% | |||
days sales outstanding | 1.73 - | 8.86 412.61% | 218.00 - | 89.02 59.16% | 72.05 19.06% | 68.15 5.42% | ||||
debt to assets | 0.01 - | 0.01 4.64% | 0.00 72.91% | 0.73 21,790.26% | 0.56 23.40% | |||||
debt to equity | 0.01 - | 0.02 7.57% | 0.05 204.50% | -1.12 2,461.12% | -1.52 36.42% | |||||
dividend yield | ||||||||||
earnings yield | -0.08 - | -0.01 84.70% | -0.05 359.34% | -0.11 109.37% | -0.15 31.58% | -0.33 123.07% | -0.52 59.29% | -0.54 3.49% | -0.24 56.19% | |
enterprise value | 149.40M - | 146.01M 2.27% | 338.46M 131.80% | 577.06M 70.50% | 637.96M 10.55% | 290.08M 54.53% | 168.56M 41.89% | 246.01M 45.95% | 436.91M 77.60% | |
enterprise value over ebitda | -12.15 - | 144.43 1,288.75% | -16.97 111.75% | -7.48 55.93% | -5.90 21.11% | -2.29 61.20% | -2.25 1.80% | -3.15 40.28% | -6.84 117.10% | |
ev to operating cash flow | -20.82 - | 34.86 267.40% | -35.36 201.45% | -15.46 56.29% | -8.98 41.88% | -2.74 69.50% | -1.99 27.52% | -2.81 41.50% | -5.72 103.60% | |
ev to sales | 8.33 - | 41.49 398.09% | 511.58 1,133.07% | 35.44K 6,828.04% | 24.58 99.93% | 3.51 85.73% | 3.82 8.95% | 5.28 38.18% | ||
free cash flow per share | -0.62 - | 0.29 146.74% | -1.01 447.08% | -2.41 137.47% | -3.48 44.48% | -4.92 41.49% | -3.83 22.06% | -3.85 0.47% | -2.66 31.03% | |
free cash flow yield | -0.04 - | 0.02 146.74% | -0.03 225.57% | -0.06 113.10% | -0.10 86.43% | -0.27 162.02% | -0.40 47.68% | -0.43 7.72% | -0.18 59.22% | |
graham net net | 1.24 - | 1.23 0.93% | 6.82 454.44% | 5.58 18.24% | 6.09 9.18% | 6.14 0.81% | -0.49 108.01% | -4.97 910.38% | -3.17 36.27% | |
graham number | 5.69 - | 2.23 60.86% | 18.07 710.72% | 24.86 37.56% | 31.11 25.14% | 24.23 22.11% | 6.48 73.25% | 20.47 215.85% | 13.43 34.38% | |
income quality | 0.57 - | -2.16 481.67% | 0.48 122.17% | 0.49 3.12% | 0.68 36.87% | 0.82 22.02% | 0.77 7.05% | 0.80 4.12% | 0.75 6.34% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | 25.27 - | -9.37 - | -1.81 80.71% | |||||||
interest debt per share | -0.08 - | 0.07 181.65% | 0.02 74.09% | 4.72 26,381.08% | 4.70 0.26% | |||||
inventory turnover | 0.27 - | 1.90 612.03% | 0.51 - | 1.07 107.74% | 1.77 65.82% | 1.65 6.76% | ||||
invested capital | 0.01 - | 0.02 7.57% | 0.05 204.50% | -1.12 2,461.12% | -1.52 36.42% | |||||
market cap | 167.38M - | 167.38M 0% | 375.46M 124.32% | 678.38M 80.68% | 685.04M 0.98% | 392.49M 42.71% | 212.52M 45.85% | 202.30M 4.81% | 432.51M 113.80% | |
net current asset value | 16.02M - | 15.29M 4.56% | 67.44M 341.00% | 88.78M 31.65% | 126.55M 42.54% | 89.97M 28.91% | 3.06M 96.60% | -96.07M 3,242.72% | -74.34M 22.62% | |
net debt to ebitda | 1.46 - | -21.13 1,545.51% | 1.85 108.78% | 1.31 29.22% | 0.44 66.84% | 0.81 85.62% | 0.59 27.46% | -0.56 195.58% | -0.07 87.72% | |
net income per share | -1.06 - | -0.16 84.70% | -2.06 1,169.60% | -4.80 133.32% | -4.90 1.97% | -5.90 20.46% | -4.96 15.94% | -4.79 3.48% | -3.55 25.92% | |
operating cash flow per share | -0.60 - | 0.35 158.38% | -0.98 381.52% | -2.37 140.59% | -3.46 45.98% | -4.86 40.53% | -3.80 21.86% | -3.84 1.06% | -2.65 31.01% | |
payables turnover | 0.01 - | 0.14 808.36% | 0.21 56.06% | 0.31 - | 0.89 188.94% | 1.38 55.37% | 1.44 3.77% | |||
receivables turnover | 211.20 - | 41.20 80.49% | 1.67 - | 4.10 144.89% | 5.07 23.55% | 5.36 5.73% | ||||
research and ddevelopement to revenue | 0.59 - | 2.29 290.55% | 32.74 1,328.66% | 2.74K 8,264.32% | 4.01 99.85% | 0.99 75.27% | 0.82 17.10% | 0.55 32.92% | ||
return on tangible assets | -0.65 - | -0.08 87.14% | -0.26 214.45% | -0.73 175.97% | -0.50 32.01% | -1.05 112.01% | -0.93 12.12% | -0.80 13.42% | -0.57 28.44% | |
revenue per share | 1.46 - | 0.84 42.66% | 0.07 91.47% | 0.00 98.78% | 0.54 61,681.77% | 2.15 296.85% | 2.82 31.26% | 2.87 1.66% | ||
roe | -0.78 - | -0.12 84.73% | -0.29 145.24% | -0.84 187.68% | -0.56 33.60% | -1.33 139.16% | -13.17 887.85% | 1.23 109.34% | 1.57 27.46% | |
roic | -0.76 - | 0.05 106.42% | -0.29 695.58% | -0.86 194.41% | -0.56 34.24% | -1.31 132.19% | -10.15 675.11% | -6.67 34.28% | -1.95 70.83% | |
sales general and administrative to revenue | 0.37 - | 1.08 195.05% | 35.08 3,148.08% | 3.34K 9,433.42% | ||||||
shareholders equity per share | 1.36 - | 1.36 0.16% | 7.05 417.70% | 5.72 18.90% | 8.78 53.58% | 4.42 49.63% | 0.38 91.49% | -3.89 1,133.56% | -2.26 41.88% | |
stock based compensation to revenue | 0.11 - | 0.77 588.23% | 27.16 3,417.64% | 1.66K 6,028.62% | 2.38 99.86% | 0.48 79.74% | 0.16 65.83% | 0.11 31.29% | ||
tangible asset value | 16.28M - | 16.31M 0.16% | 68.52M 320.16% | 90.09M 31.50% | 180.30M 100.13% | 96.36M 46.56% | 8.41M 91.27% | -88.74M 1,154.81% | -65.21M 26.51% | |
tangible book value per share | 1.36 - | 1.36 0.16% | 7.05 417.70% | 5.72 18.90% | 8.78 53.58% | 4.42 49.63% | 0.38 91.49% | -3.89 1,133.56% | -2.26 41.88% | |
working capital | 16.89M - | 18.90M 11.90% | 67.44M 256.73% | 88.78M 31.65% | 129.15M 45.48% | 94.18M 27.08% | 92.01M 2.31% | 104.99M 14.11% | 137.97M 31.42% |
All numbers in (except ratios and percentages)